Leap Therapeutics plans to raise $58,888,888 through PIPE financing, led by Winklevoss Capital

ChainCatcher news, Nasdaq-listed company Leap Therapeutics announced that it has reached a securities purchase agreement to raise $58,888,888 through a public equity private placement (PIPE), led by Winklevoss Capital. The transaction is expected to be completed on October 8, and the company will use the funds to launch a digital asset treasury.

It is reported that Winklevoss Capital will have the right to nominate two individuals to the Leap board of directors, one of whom will also serve as the chairman of the board.